Chronic myeloproliferative disorder
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
366
|
47
|
0.060 |
None |
1.000 |
6 |
|
1998 |
2017 |
Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement
|
disease |
|
Neoplastic Process
|
22
|
|
0.050 |
None |
1.000 |
5 |
|
1999 |
2004 |
Post-traumatic amnesia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
9
|
|
0.020 |
None |
1.000 |
2 |
|
2019 |
2019 |
Mental Depression
|
disease |
Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
1478
|
271
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Depressive disorder
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1719
|
297
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Hepatitis B
|
disease |
Digestive System Diseases; Infections
|
Disease or Syndrome
|
1449
|
519
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2015 |
Impaired cognition
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
1630
|
348
|
0.020 |
None |
1.000 |
2 |
|
2017 |
2020 |
Precursor T-cell lymphoblastic lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
30
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
Adult T Lymphoblastic Lymphoma
|
disease |
|
Neoplastic Process
|
21
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
Childhood T Lymphoblastic Lymphoma
|
disease |
|
Neoplastic Process
|
21
|
|
0.020 |
None |
1.000 |
2 |
|
2011 |
2017 |
CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME
|
disease |
|
Disease or Syndrome
|
17
|
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2011 |
Primary Myelofibrosis
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
282
|
29
|
0.010 |
None |
1.000 |
1 |
|
1999 |
1999 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Aphasia
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
86
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
2096
|
1536
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Child attention deficit disorder
|
disease |
Mental Disorders
|
Disease or Syndrome
|
26
|
|
0.010 |
None |
1.000 |
1 |
|
2003 |
2003 |
Down Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
766
|
80
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Glomerulonephritis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
391
|
7
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Hemangioma
|
disease |
Neoplasms
|
Neoplastic Process
|
256
|
24
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Profound Mental Retardation
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders; Behavior and Behavior Mechanisms
|
Mental or Behavioral Dysfunction
|
160
|
3
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Acute monocytic leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
633
|
22
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Acute Promyelocytic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
651
|
21
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |